Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs in Acute Ischemic Stroke
NCT07084012Phase 2Recruiting
- Sponsor
- Wingor Biotechnology
- Start
- Aug 2025
- Primary completion
- May 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in ischemic stroke, sponsored by Wingor Biotechnology. Started Aug 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07084012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07084012.